Q32 Bio Balance Sheet Health
Financial Health criteria checks 5/6
Q32 Bio has a total shareholder equity of $18.3M and total debt of $15.3M, which brings its debt-to-equity ratio to 83.5%. Its total assets and total liabilities are $104.5M and $86.2M respectively.
Key information
83.5%
Debt to equity ratio
US$15.28m
Debt
| Interest coverage ratio | n/a |
| Cash | US$89.08m |
| Equity | US$18.30m |
| Total liabilities | US$86.25m |
| Total assets | US$104.54m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0T6G's short term assets ($93.9M) exceed its short term liabilities ($14.4M).
Long Term Liabilities: 0T6G's short term assets ($93.9M) exceed its long term liabilities ($71.9M).
Debt to Equity History and Analysis
Debt Level: 0T6G has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 0T6G's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0T6G has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0T6G has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 25.9% each year.